Mary Sell

Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors.

D. Porter, S. Luger, E. Hexner, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Donor Apheresis Blood Volumes Are Associated with a Reduction in Relapse Risk and Improved Survival in Reduced Intensity Allogeneic Transplants with Unrelated Donors

D. Porter, S. Luger, E. Hexner, 2018 .

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.

D. Porter, R. Mick, T. Kambayashi, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rapid prediction of stem cell mobilization using volume and conductivity data from automated hematology analyzers

C. Villa, W. Hwang, U. O’Doherty, 2018, Transfusion.

Plerixafor mobilization leads to a lower ratio of CD34+ cells to total nucleated cells which results in greater storage costs

Y. Tanhehco, E. Stadtmauer, J. Adamski, 2010, Journal of clinical apheresis.

Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma.

D. Porter, A. Nazha, S. Schuster, 2009 .

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.

D. Porter, R. Mick, T. Kambayashi, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.